Timothy T. Chole
Corporate Officer/Principal presso ROCKWELL MEDICAL, INC.
Patrimonio netto: 45 042 $ in data 31/05/2024
Profilo
Timothy T.
Chole is currently the Chief Commercial Officer at Rockwell Medical, Inc. He previously worked as the Marketing Director at Gambro AB and as the Director-Product Marketing at Cochlear Americas.
Mr. Chole completed his undergraduate degree at the University of California.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ROCKWELL MEDICAL, INC.
0.08% | 21/05/2024 | 25 665 ( 0.08% ) | 45 042 $ | 31/05/2024 |
Posizioni attive di Timothy T. Chole
| Società | Posizione | Inizio |
|---|---|---|
| ROCKWELL MEDICAL, INC. | Corporate Officer/Principal | 30/05/2024 |
Precedenti posizioni note di Timothy T. Chole
| Società | Posizione | Fine |
|---|---|---|
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Vendite & Marketing | 01/10/2013 |
| Cochlear Americas | Corporate Officer/Principal | - |
Formazione di Timothy T. Chole
| University of California | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ROCKWELL MEDICAL, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Gambro AB
Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Health Technology |
| Cochlear Americas |
- Borsa valori
- Insiders
- Timothy T. Chole
